Status:
RECRUITING
Diagnosis of Adrenal Insufficiency in Liver Cirrhosis Patients
Lead Sponsor:
Seoul National University Hospital
Collaborating Sponsors:
Korea Institute of Science and Technology
Conditions:
Adrenal Insufficiency
Liver Cirrhosis
Eligibility:
All Genders
18+ years
Brief Summary
Patients with liver cirrhosis (LC) often exhibit fatigue, poor oral intake, and abdominal discomfort, which are the symptoms that are also shown in subjects with adrenal insufficiency (AI). Controvers...
Eligibility Criteria
Inclusion
- patients diagnosed of liver cirrhosis
Exclusion
- pregnant
- history of getting surgery of pituitary resection or adrenalectomy
- patients with diagnosis of pituitary adenoma or adrenal adenoma
- patients take steroid within 3 months
- patients take medication related to synthesis of steroid or cortisol binding protein within 3 months (i.e. ketoconazole, etomidate, sex hormone, oral contraceptive)
- patients take albumin, free frozen plasma, terlipressin, glypressin within 1 month
- patients with acute medical condition
Key Trial Info
Start Date :
December 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 31 2024
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06206655
Start Date
December 1 2023
End Date
August 31 2024
Last Update
January 22 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Hospital
Seoul, South Korea, 03080